SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,880,000 | +15.4% | 23,760 | +9.1% | 0.00% | +33.3% |
| Q2 2023 | $2,495,000 | -30.7% | 21,788 | -16.6% | 0.00% | -25.0% |
| Q1 2023 | $3,601,000 | +8.5% | 26,124 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $3,318,000 | -10.3% | 25,602 | -21.2% | 0.00% | -20.0% |
| Q3 2022 | $3,697,000 | +31.0% | 32,488 | -13.7% | 0.01% | +66.7% |
| Q2 2022 | $2,823,000 | -3.4% | 37,660 | +0.6% | 0.00% | +50.0% |
| Q1 2022 | $2,923,000 | +110.9% | 37,424 | +143.4% | 0.00% | +100.0% |
| Q4 2021 | $1,386,000 | +0.9% | 15,378 | +3.6% | 0.00% | 0.0% |
| Q3 2021 | $1,373,000 | -90.1% | 14,848 | -91.7% | 0.00% | -90.9% |
| Q2 2021 | $13,882,000 | +1232.2% | 178,568 | +1177.1% | 0.01% | +1000.0% |
| Q1 2021 | $1,042,000 | -99.0% | 13,982 | -97.8% | 0.00% | -99.4% |
| Q4 2020 | $109,332,000 | +43.4% | 641,282 | +18.1% | 0.16% | +24.0% |
| Q3 2020 | $76,262,000 | -10.1% | 543,062 | +2.7% | 0.13% | -11.6% |
| Q2 2020 | $84,818,000 | +3524.7% | 528,987 | +2111.3% | 0.15% | +2820.0% |
| Q1 2020 | $2,340,000 | -24.2% | 23,922 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $3,087,000 | +78.2% | 23,922 | +4.0% | 0.00% | +33.3% |
| Q3 2019 | $1,732,000 | -99.0% | 23,000 | -97.9% | 0.00% | -96.8% |
| Q2 2019 | $166,122,000 | +298.1% | 1,093,272 | +212.3% | 0.09% | +32.4% |
| Q1 2019 | $41,728,000 | -23.0% | 350,097 | -29.5% | 0.07% | -32.4% |
| Q4 2018 | $54,223,000 | -34.8% | 496,866 | -3.5% | 0.10% | -22.2% |
| Q3 2018 | $83,170,000 | +64.2% | 514,952 | +34.4% | 0.14% | +55.2% |
| Q2 2018 | $50,637,000 | +870.4% | 383,093 | +444.0% | 0.09% | +770.0% |
| Q1 2018 | $5,218,000 | +307.7% | 70,423 | +206.2% | 0.01% | +400.0% |
| Q4 2017 | $1,280,000 | -14.5% | 23,000 | -30.3% | 0.00% | -33.3% |
| Q3 2017 | $1,497,000 | +34.6% | 33,000 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $1,112,000 | +13.8% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $977,000 | +8.0% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $905,000 | +2.3% | 33,000 | -27.3% | 0.00% | 0.0% |
| Q1 2016 | $885,000 | -40.5% | 45,362 | +17.7% | 0.00% | -33.3% |
| Q4 2015 | $1,487,000 | -21.8% | 38,533 | -35.0% | 0.00% | -25.0% |
| Q3 2015 | $1,902,000 | -30.6% | 59,241 | -34.2% | 0.00% | -20.0% |
| Q2 2015 | $2,739,000 | +330.0% | 90,000 | +87.5% | 0.01% | +400.0% |
| Q1 2015 | $637,000 | -8.3% | 48,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $695,000 | -23.4% | 48,000 | +11.6% | 0.00% | -50.0% |
| Q3 2014 | $907,000 | -15.4% | 43,000 | +19.4% | 0.00% | 0.0% |
| Q2 2014 | $1,072,000 | +23.9% | 36,000 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $865,000 | +18.0% | 36,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $733,000 | -18.3% | 36,000 | +89.5% | 0.00% | -50.0% |
| Q3 2013 | $897,000 | +7.2% | 19,000 | -13.6% | 0.00% | 0.0% |
| Q2 2013 | $837,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |